Alprostadil topical - VIVUS

Drug Profile

Alprostadil topical - VIVUS

Alternative Names: ALISTA; Prostaglandin E1 topical - VIVUS

Latest Information Update: 10 Jun 2009

Price : $50

At a glance

  • Originator VIVUS
  • Developer AndroSolutions; Asivi; VIVUS
  • Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Female sexual dysfunction

Most Recent Events

  • 10 Jun 2009 Discontinued - Phase-II for Female sexual dysfunction in USA (Topical)
  • 03 Oct 2006 Final results from a phase IIb clinical trial in patients with Female sexual arousal disorder have been added to the Women's Health therapeutic trials section
  • 07 Dec 2005 VIVUS has completed enrolment in the phase IIb trial for Female sexual dysfunction in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top